SPRAVATO®
SPRAVATO®, also known by its generic name esketamine, is a groundbreaking medication designed to address treatment-resistant clinical depression, a condition where traditional antidepressants have proven ineffective. Approved by the U.S. Food and Drug Administration (FDA), SPRAVATO® represents a significant advancement in the field of mental health treatment.
SPRAVATO® operates on a unique mechanism of action compared to traditional antidepressants. It is an NMDA receptor antagonist, and it works by influencing glutamate, a neurotransmitter. This novel approach helps regulate mood and reduce depressive symptoms.
The duration of your SPRAVATO® treatment will be decided in partnership with your healthcare provider, who will take into consideration how you respond to the treatment and the stability of that response.
After completing eight weeks of treatment, your healthcare provider will evaluate how you are feeling and make adjustments to the dosing frequency as needed. It is essential to remember that SPRAVATO® should be taken alongside an oral antidepressant as part of your treatment plan.
SPRAVATO® is administered as a nasal spray, typically under the supervision of a healthcare provider in a healthcare setting.
On treatment day it is essential to remember:
- Plan transportation for treatment days as you will not be able to drive.
- Self-administer the nasal spray under healthcare provider supervision.
- Expect a monitoring period of at least two hours to check for side effects.
- You may only leave the treatment facility when your healthcare provider gives the go-ahead.
- Avoid driving, operating machinery, or activities requiring full alertness until the day after treatment, following a restful sleep.
Clinical trials have shown that SPRAVATO® can produce rapid and significant improvements in depressive symptoms, often when other treatments have failed. However, it may not be effective for everyone, and its long-term benefits are still being studied.
Like any medication, SPRAVATO® has potential side effects, including sedation, and increased blood pressure. Patients are closely monitored during and after treatment to ensure safety.
SPRAVATO® is typically reserved for individuals who have not responded adequately to at least two different antidepressant treatments. Healthcare providers carefully evaluate patients to determine if SPRAVATO® is a suitable option.
Learn more about this revolutionary treatment with a fast and easy SPRAVATO® factsheet.
In-Office Nasal Spray Treatment
At My Buoyant Health, we are committed to providing cutting-edge mental health care solutions; our in-office SPRAVATO® nasal spray treatment is no exception. This innovative treatment option addresses treatment-resistant clinical depression and offers new hope for individuals who have not found relief with traditional antidepressant medications.
Our experienced healthcare provider, Russell Horning, PMHNP-BC, will oversee every aspect of the SPRAVATO® treatment process. From the initial evaluation to the administration of the nasal spray, you can trust that you are in capable and compassionate hands.
Your safety is our top priority. Throughout the SPRAVATO® treatment sessions, we closely monitor your response and any potential side effects. Our commitment to your well-being means you can undergo treatment with confidence.
We understand that mental health is a highly individualized journey, and our approach to SPRAVATO® treatment reflects this. We tailor the treatment plan to your specific needs, ensuring that you receive the correct dosage and frequency of sessions for the best possible outcomes.
Beyond SPRAVATO® treatment, we offer various mental health services to support your overall well-being. Our holistic approach includes therapy, medication management, and lifestyle adjustments to help you achieve lasting mental wellness.
If you or a loved one is struggling with treatment-resistant depression, it is essential to consult a mental health professional to explore treatment options, including SPRAVATO®, and determine the best approach for your specific needs.
SPRAVATO® Treatment for Clinical Depression in Phoenix, AZ
Ready to take the first step toward relief from treatment-resistant clinical depression? Your journey to improved mental health begins with us. If you are an established patient and wish to contact us directly, you can do so via your patient portal, or you may message us through the Healow app. Request your appointment now online or by calling us at (602) 510-6582. Connect with My Buoyant Health to explore the potential of SPRAVATO® nasal spray treatment. Let us pave the way to a brighter, more buoyant future together.
